• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

EIHSX:US

12.76 USD 0.04 0.31%

As of 09:29:30 ET on 12/19/2014.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (EIHSX)

Year To Date: +31.40% 3-Month: +8.99% 3-Year: +31.63% 52-Week Range: 9.65 - 12.80
1-Month: +3.24% 1-Year: +34.61% 5-Year: +19.60% Beta vs SPX: 0.94

Mutual Fund Chart for EIHSX

No chart data available.
  • EIHSX:US 12.76
  • 1M
  • 1Y
Interactive EIHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for EIHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 10-01-2009 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for EIHSX

NAV (on 2014-12-19) 12.76
Assets (M) (on 2014-11-28) 1,637.70
Fund Leveraged N
Minimum Investment 250,000.00
Minimum Subsequent Investment 0.00

Dividends for EIHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-16) 0.56
Dividend Yield (ttm) 16.57

Fees & Expenses for EIHSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.91
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.21

Top Fund Holdings for EIHSX

Filing Date: 09/30/2014
Name Position Value % of Total
AbbVie Inc 1,140,000 65,846,400 4.435%
Roche Holding AG 221,409 65,382,725 4.404%
Bristol-Myers Squibb Co 1,230,000 62,951,400 4.240%
HCA Holdings Inc 842,000 59,377,840 3.999%
Gilead Sciences Inc 548,200 58,355,890 3.931%
Merck & Co Inc 932,000 55,248,960 3.721%
Regeneron Pharmaceuticals Inc 153,000 55,159,560 3.715%
Amgen Inc 392,000 55,060,320 3.709%
Biogen Idec Inc 149,600 49,489,176 3.333%
Actavis plc 195,300 47,121,984 3.174%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil